May 8, 2025 04:05PM
Apr 30, 2025 07:10AM
Mar 27, 2025 08:28AM
Mar 27, 2025 07:00AM
Mar 13, 2025 04:05PM
Jan 29, 2025 07:03AM
Jan 29, 2025 07:00AM Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)
Nov 29, 2024 07:43AM
Nov 26, 2024 08:00AM
Nov 7, 2024 04:05PM
Oct 9, 2024 07:22AM
Oct 8, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 8, 2024 04:05PM Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates
Aug 6, 2024 08:00AM
Jul 16, 2024 10:54AM
Jul 9, 2024 08:00AM
Jun 24, 2024 07:02AM
Jun 24, 2024 07:00AM
Mar 21, 2024 04:05PM
Mar 12, 2024 06:32AM Regulus Therapeutics (RGLS) Reports Positive Topline Data from the Second Cohort in Phase 1b Trial of RGLS8429
Mar 12, 2024 06:30AM
Aug 11, 2022 04:10PM
Jun 21, 2022 08:01AM
Jun 21, 2022 08:00AM
May 12, 2022 04:05PM
May 11, 2022 08:01AM
May 11, 2022 08:00AM Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mar 10, 2022 04:05PM
Jan 21, 2022 09:17AM
Jan 20, 2022 06:07PM
Jan 20, 2022 05:19PM
Jan 20, 2022 05:18PM
Dec 1, 2021 08:30AM
Nov 10, 2021 04:05PM Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates
Oct 13, 2021 09:24AM
Oct 12, 2021 06:11PM
Oct 12, 2021 04:05PM
Oct 12, 2021 04:05PM
Sep 30, 2021 04:55PM
Sep 9, 2021 04:40PM
Sep 2, 2021 07:02AM UPDATE: Cantor Fitzgerald Starts Regulus Therapeutics (RGLS) at Overweight
Aug 10, 2021 04:05PM
Aug 3, 2021 05:15PM
Jun 25, 2021 07:06AM
Jun 25, 2021 07:05AM
Jun 21, 2021 07:00AM
May 21, 2021 08:08AM
May 21, 2021 08:07AM Regulus Therapeutics Announces Incremental Update of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program
May 14, 2021 04:07PM

322,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All